ICON plc and Advarra Partner to Launch Connected Clinical Trial Network

ICON plc, a world-leading clinical research organisation, and Advarra, the market leader in regulatory reviews and a leading provider of connected, intelligence-powered research technology, have entered a definitive partnership agreement to introduce a new ‘research-ready,’ connected site network model for clinical trials. 

The partnership will integrate ICON’s global clinical trial solutions and services with Advarra’s site CTMSs, eISF, and eSource systems, which are already used by more than 50,000 investigators worldwide, including researchers at 90 of the top 125 academic medical centers, 90 percent of NCI-Designated Cancer Centers, and the top site networks. 

ICON and Advarra will work together to expand access to clinical trials by enabling more research sites worldwide to support today’s increasingly complex study requirements. The companies plan to equip emerging and research-naïve sites, along with select sites working with ICON, with Advarra’s site technology, helping standardise operations and reduce manual processes. This will provide sponsors with a way to accelerate study startup and engage a broader and more geographically diverse set of research sites, and improve patient recruitment and retention.

“Research sites should not have to adapt their operations for every new study or sponsor, and ICON and Advarra are focused on meeting sites where they are, prioritising their needs and removing that burden through this partnership,” said Barry Balfe, CEO of ICON plc. “By aligning ICON’s workflows with the systems sites already use every day, we’re advancing a more practical and scalable way to run trials that reduces administrative burden on sites.”